STOCK TITAN
  1. Home
  2. Sec-filings
  3. CWK
  4. [144] Cushman & Wakefield Ltd. SEC Filing

Cushman & Wakefield (NYSE: CWK) files to sell 16,000 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Cushman & Wakefield plc is registering a proposed sale of up to 16,000 shares of common stock through Fidelity Brokerage Services LLC, with an estimated aggregate value of $222,080.00. The filing also lists 234,713,708 common shares outstanding and details that the shares to be sold were acquired through multiple restricted stock vesting compensation awards from 2021 through 2026.

Positive

  • None.

Negative

  • None.
Shares to be sold 16,000 shares Common stock proposed for sale through Fidelity Brokerage Services LLC
Aggregate value of shares to be sold $222,080.00 Estimated aggregate market value of the 16,000 common shares
Shares outstanding 234,713,708 shares Reported common shares outstanding for Cushman & Wakefield plc
Restricted stock vesting grant (example) 6,355 shares Sum of 5,983 and 372 shares from 02/21/2025 and 02/24/2025 vesting entries
Form 144 regulatory
"144: Securities Information Common | Fidelity Brokerage Services LLC"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
restricted stock vesting financial
"Common | 02/27/2021 | Restricted Stock Vesting | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
compensation financial
"02/27/2021 | Compensation Common | 02/25/2022"
Securities To Be Sold regulatory
"144: Securities To Be Sold Common | 02/27/2021"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

How many CWK shares are proposed to be sold under this Form 144?
The filing covers a proposed sale of up to 16,000 shares of Cushman & Wakefield common stock, to be sold through Fidelity Brokerage Services LLC as disclosed in the securities information section.

What is the estimated value of the CWK shares to be sold?
The proposed sale of 16,000 CWK shares has an estimated aggregate value of $222,080.00. This reflects the valuation reported in the Form 144 securities information table for the common stock to be sold.

How many Cushman & Wakefield (CWK) shares are reported outstanding?
The Form 144 lists 234,713,708 Cushman & Wakefield common shares outstanding. This figure provides context for the size of the proposed 16,000-share sale relative to the company’s overall equity base.

What is the source of the CWK shares being sold in this Form 144?
The shares were acquired through multiple restricted stock vesting awards designated as compensation from the issuer between 2021 and 2026, as shown in the "Securities To Be Sold" compensation entries.

Which broker is handling the proposed CWK stock sale?
The proposed sale of 16,000 CWK common shares is listed under Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917, in the Form 144 securities information section.

On which exchange are the CWK shares listed for this planned sale?
The common shares referenced in the Form 144 are identified as trading on the NYSE, as indicated in the securities information section describing the 16,000-share proposed sale.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR